BCL9L 抗体 (N-Term)
(4 references)Quick Overview for BCL9L 抗体 (N-Term) (ABIN1881110)
抗原
See all BCL9L 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 147-176, N-Term
-
纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
免疫原
- This BCL9L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 147-176 amino acids from the N-terminal region of human BCL9L.
-
亚型
- Ig Fraction
-
-
anti-B-Cell CLL/lymphoma 9-Like (BCL9L) (AA 606-751) antibody
BCL9L 适用: 人 ELISA, FACS 宿主: 小鼠 Monoclonal 1C9G2 unconjugated
anti-B-Cell CLL/lymphoma 9-Like (BCL9L) (AA 606-751) antibodyBCL9L 适用: 人 ELISA, IHC 宿主: 小鼠 Monoclonal 3B9C1 unconjugated
anti-B-Cell CLL/lymphoma 9-Like (BCL9L) (N-Term) antibodyBCL9L 适用: 人, 小鼠, 大鼠 WB, ELISA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- WB: 1:1000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
有效期
- 6 months
-
-
-
: "Allosteric remodelling of the histone H3 binding pocket in the Pygo2 PHD finger triggered by its binding to the B9L/BCL9 co-factor." in: Journal of molecular biology, Vol. 401, Issue 5, pp. 969-84, (2010) (PubMed).
: "A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential." in: Gastroenterology, Vol. 137, Issue 1, pp. 165-75, (2009) (PubMed).
: "Crystal structure of a beta-catenin/BCL9/Tcf4 complex." in: Molecular cell, Vol. 24, Issue 2, pp. 293-300, (2006) (PubMed).
: "Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions." in: Genes & development, Vol. 18, Issue 18, pp. 2225-30, (2004) (PubMed).
-
: "Allosteric remodelling of the histone H3 binding pocket in the Pygo2 PHD finger triggered by its binding to the B9L/BCL9 co-factor." in: Journal of molecular biology, Vol. 401, Issue 5, pp. 969-84, (2010) (PubMed).
-
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
-
别名
- BCL9L
-
背景
- Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity).
-
分子量
- 157129
-
NCBI登录号
- NP_872363
-
UniProt
- Q86UU0
-
途径
- Stem Cell Maintenance
抗原
-
